HeartSciences Inc. · NASDAQ:HSCS

HeartSciences Inc. financial statements

HeartSciences Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022
Revenue4.32K4.35K18.6K5.15K14.4K
Cost of revenue1.77K1.88K6.08K2.80K7.89K
Gross profit2.55K2.47K12.5K2.35K6.48K
Research and development2.84M4.39M2.88M2.46M3.00M
Selling, general and administrative5.58M3.97M3.44M3.65M1.71M
Operating income-8.41M-8.35M-6.31M-6.11M-4.71M
Depreciation and amortization27.8K37.6K27.9K26.9K26.6K
EBITDA-8.39M-8.31M-6.28M-6.09M-4.68M
Interest expense753.0K500.5K354.1K243.2K371.6K
Income tax00
Net income-9.14M-8.77M-6.61M-6.35M-4.83M
Earnings per share, basic-3.48-9.34-18.74-80.00-1.45
Earnings per share, diluted-9.34-18.74-80.00-1.45

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022
Cash and equivalents1.66M1.10M5.81M1.66M918.3K
Receivables4.35K2.32K
Inventory655.6K650.3K629.2K676.4K674.1K
Current assets2.58M2.17M7.35M2.70M1.93M
Property, plant and equipment39.3K63.5K98.0K61.4K70.0K
Total assets5.26M4.22M9.50M3.29M2.09M
Accounts payable318.3K318.7K448.2K631.4K694.7K
Current liabilities4.86M3.70M1.75M1.83M3.47M
Total liabilities5.04M4.02M2.19M3.06M8.15M
Shareholders' equity226.1K205.2K7.32M230.6K-6.06M
Shares outstanding3.19M1.12M676.6K101.3K3.32M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022
Cash from operations-7.43M-7.41M-6.07M-5.77M-3.64M
Capital spending-3.55K-3.16K-64.5K-18.3K-1.93K
Free cash flow-7.43M-7.42M-6.13M-5.79M-3.65M
Cash from investing-44.5K-30.2K-125.3K-18.3K-1.93K
Cash from financing8.03M2.73M10.3M6.53M3.84M
Change in cash558.7K-4.71M4.15M742.2K194.8K